Skip to main navigation
Skip to search
Skip to main content
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Search by expertise, name or affiliation
Prot #13676-01: A Phase 1 Multidose Study To Evaluate The Safety And Tolerability Of XmAb®13676 In Patients With Cd20-Expressing Hematologic Malignancies
Karmali, Reem
(PD/PI)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
9/1/17
→
9/1/20
Funding
Chiltern International, Inc.
(Prot #13676-01)
Xencor, Inc.
(Prot #13676-01)
View all
View less